|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Personal history of benign neoplasm
ICD-10 (CM) Code and Descriptor
|
Z86.018 |
Personal history of other benign neoplasm
This code is considered unacceptable as a principal diagnosis.
|
Z86018 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 3.80%
|
14.04%
|
11.86%
|
9.71%
|
8.20%
|
7.37%
|
6.60%
|
6.12%
|
4.95%
|
4.50%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z86.018*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
821
|
824
|
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
318
|
319
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
270
|
271
|
|
A9585
|
GADOBUTROL INJECTION |
151
|
11,480
|
|
82565
|
ASSAY OF CREATININE |
135
|
135
|
|
G1004
|
CDSM NDSC |
129
|
139
|
|
A9577
|
INJ MULTIHANCE |
118
|
1,659
|
|
80053
|
COMPREHEN METABOLIC PANEL |
105
|
105
|
|
84443
|
ASSAY THYROID STIM HORMONE |
97
|
97
|
|
83835
|
ASSAY OF METANEPHRINES |
95
|
97
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
89
|
105
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
80
|
7,593
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
77
|
10,016
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
72
|
72
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
67
|
146
|
|
84439
|
ASSAY OF FREE THYROXINE |
67
|
67
|
|
84146
|
ASSAY OF PROLACTIN |
66
|
66
|
|
82533
|
TOTAL CORTISOL |
66
|
67
|
|
76830
|
TRANSVAGINAL US NON-OB |
61
|
61
|
|
80061
|
LIPID PANEL |
58
|
58
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z86.018 related to the following DRG Codes:
951
|
